Guided Therapeutics (GTHP) Total Liabilities (2010 - 2026)
Guided Therapeutics (GTHP) posted Total Liabilities of $7.3 million for Q4 2025, up 11.93% sequentially from $6.5 million in Q3 2025, and up 16.96% YoY from $6.3 million in Q4 2024.
Guided Therapeutics (GTHP) Total Liabilities (2010 - 2026) Analysis & Trends
Guided Therapeutics has reported Total Liabilities for 16 years, with the latest figure at $7.3 million in Q4 2025.
- Quarterly Total Liabilities rose 16.96% year-over-year to $7.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.3 million (up 16.96% YoY) and the FY2025 annual result came in at $7.3 million, up 16.96% from the prior year.
- Total Liabilities improved to $7.3 million in Q4 2025 per GTHP's latest filing, from $6.5 million in the prior quarter.
- Over five years, Total Liabilities peaked at $10.3 million in Q1 2021 and troughed at $5.5 million in Q4 2023.
- A 5-year average of $6.6 million and a median of $6.3 million in 2024 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2021 and 2025: Total Liabilities sank 57.44% in 2021, then rose 16.96% in 2025.
- Over 5 years, Total Liabilities stood at $7.5 million in 2021, then decreased by 16.51% to $6.2 million in 2022, then retreated by 12.39% to $5.5 million in 2023, then climbed by 14.47% to $6.3 million in 2024, then gained by 16.96% to $7.3 million in 2025.
- According to Business Quant data, Total Liabilities over the past three periods registered $7.3 million, $6.5 million, and $6.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.94 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 3.14 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.83 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.03 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 17.70 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.51 Bn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | 6.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.96 Mn |
| Dec 31, 2025 | 7.33 Mn |
| Sep 30, 2025 | 6.55 Mn |
| Jun 30, 2025 | 6.41 Mn |
| Mar 31, 2025 | 6.00 Mn |
| Dec 31, 2024 | 6.27 Mn |
| Sep 30, 2024 | 6.17 Mn |
| Jun 30, 2024 | 5.92 Mn |
| Mar 31, 2024 | 5.51 Mn |
| Dec 31, 2023 | 5.48 Mn |
| Sep 30, 2023 | 5.53 Mn |
| Jun 30, 2023 | 5.66 Mn |
| Mar 31, 2023 | 5.75 Mn |
| Dec 31, 2022 | 6.25 Mn |
| Sep 30, 2022 | 6.52 Mn |
| Jun 30, 2022 | 7.27 Mn |
| Mar 31, 2022 | 7.18 Mn |
| Dec 31, 2021 | 7.49 Mn |
| Sep 30, 2021 | 6.82 Mn |
| Jun 30, 2021 | 7.39 Mn |